We are searching data for your request:
Upon completion, a link will appear to access the found materials.
Approvals of plant protection products containing glyphosate extended
A few months ago, it became known that the federal government would ban the use of the controversial weed poison glyphosate at the end of 2023 and restrict the use of the agent from next year. However, approvals of plant protection products containing glyphosate are now being extended.
According to the German Federal Agency for the Environment and Nature Conservation (BUND), glyphosate is the best-selling weed killer in the world and a so-called "total herbicide" that kills any plant that has not been genetically modified to survive herbicide use. According to the cancer research agency of the WHO, the drug is likely to be carcinogenic in humans. The Federal Office of Consumer Protection and Food Safety (BVL) is now extending approvals of some plant protection products containing glyphosate, which were limited until December 2019, by a maximum of one year.
Legal right to renewal of approvals
According to a statement, after the approval of the active ingredient glyphosate by the EU Commission in December 2017, the application for renewal of the approval was applied for some plant protection products containing glyphosate in Germany.
According to the information, the processing of these applications could not be completed within the prescribed deadlines. And if this is not the responsibility of the applicants, they have a legal right to have existing approvals extended. Therefore, the BVL initially extended it until December 15 or December 31, 2019.
According to the Federal Office, it is not yet possible for some of these crop protection products to make timely decisions on the applications, since prescribed steps in the approval process could not be completed. There are different reasons for this depending on the plant protection product, for example:
- The zonal rapporteur Member State (zRMS) has not yet completed its assessment of the application. This also applies to some applications where Germany is responsible for the evaluation.
- The approval decision of the zRMS has been made. The examination as to whether and, if so, under what conditions an approval can be granted in Germany could not be completed.
Against this background, the BVL must extend the approvals concerned in accordance with Article 43 (6) of Regulation (EC) No. 1107/2009. "In order to give dealers and users planning security for the coming season and treat applicants equally, most existing approvals will be extended until December 15, 2020," writes the BVL.
Possible cancer risk
The pesticide glyphosate from Bayer's Monsanto subsidiary was classified as "probably carcinogenic" by the International Agency for Research on Cancer (IARC), which is part of the World Health Organization (WHO).
However, not all experts share this assessment. For example, the controversial drug is still rated as "non-carcinogenic" by the United States Environmental Protection Agency.
And the Federal Ministry of Food and Agriculture (BMEL) writes: “If the active ingredient glyphosate is used correctly and as intended, there is no doubt about the harmlessness to health. This is also confirmed by the additional scientific review by the European Chemicals Agency (ECHA). ECHA has classified glyphosate as not carcinogenic. ”(Ad)
Author and source information
This text corresponds to the requirements of the medical literature, medical guidelines and current studies and has been checked by medical doctors.